Cargando…

METH-2 silencing and promoter hypermethylation in NSCLC

The antiangiogenic factor METH-2 (ADAMTS-8) was identified in a previous dual-channel cDNA microarray analysis to be at least two-fold under-represented in 85% (28 out of 33) of primary non-small-cell lung carcinomas (NSCLCs). This observation has been validated in an independent series of NSCLCs an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dunn, J R, Panutsopulos, D, Shaw, M W, Heighway, J, Dormer, R, Salmo, E N, Watson, S G, Field, J K, Liloglou, T
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747718/ https://www.ncbi.nlm.nih.gov/pubmed/15328519 http://dx.doi.org/10.1038/sj.bjc.6602107

Ejemplares similares

Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer
por: Shaw, R J, et al.
Publicado: (2009)

Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer
por: Lim, S L, et al.
Publicado: (2008)

RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer
por: Endoh, M, et al.
Publicado: (2005)

Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer
por: Cheng, Y Y, et al.
Publicado: (2008)

Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia
por: Honda, T, et al.
Publicado: (2004)

Hypermethylation of genes in testicular embryonal carcinomas
por: Cheung, Hoi-Hung, et al.
Publicado: (2016)

DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer
por: Kawakami, K, et al.
Publicado: (2006)

Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia
por: Scardocci, A, et al.
Publicado: (2006)

Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma
por: Lindsey, J C, et al.
Publicado: (2007)

Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer
por: De Faveri, L E, et al.
Publicado: (2013)

Promoter hypermethylation of MGMT, CDH1, RAR-β and SYK tumour suppressor genes in granulosa cell tumours (GCTs) of ovarian origin
por: Dhillon, V S, et al.
Publicado: (2004)

Loss of heterozygosity at 9q33 and hypermethylation of the DBCCR1 gene in oral squamous cell carcinoma
por: Gao, S, et al.
Publicado: (2004)

Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer
por: Deng, G, et al.
Publicado: (2002)

Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability
por: Smith, S L, et al.
Publicado: (2005)

RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker
por: Misawa, A, et al.
Publicado: (2009)

The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma
por: Hatzimichael, E, et al.
Publicado: (2012)

Epigenetic silencing of a multifunctional plant stress regulator
por: Zander, Mark, et al.
Publicado: (2019)

PIE-1 SUMOylation promotes germline fates and piRNA-dependent silencing in C. elegans
por: Kim, Heesun, et al.
Publicado: (2021)

DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers
por: Ying, J, et al.
Publicado: (2009)

Frequent downregulation of 14-3-3 σ protein and hypermethylation of 14-3-3 σ gene in salivary gland adenoid cystic carcinoma
por: Uchida, D, et al.
Publicado: (2004)

Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells
por: Hong, D, et al.
Publicado: (2009)

Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours
por: Murai, M, et al.
Publicado: (2005)

Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours
por: Dunn, J R, et al.
Publicado: (2006)

LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition
por: Mahoney, C L, et al.
Publicado: (2009)

The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer
por: Shah, R, et al.
Publicado: (2009)

Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC
por: Yang, Qin, et al.
Publicado: (2022)

Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
por: Esopi, David, et al.
Publicado: (2020)

Sequential gene promoter methylation during HPV-induced cervical carcinogenesis
por: Henken, F E, et al.
Publicado: (2007)

DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma
por: Seng, T J, et al.
Publicado: (2008)

TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations
por: Labussière, M, et al.
Publicado: (2014)

SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma
por: Astuti, D, et al.
Publicado: (2004)

BCL7A is silenced by hypermethylation to promote acute myeloid leukemia
por: Patiño-Mercau, Juan Rodrigo, et al.
Publicado: (2023)

Lipoprotein lipase is frequently overexpressed or translocated in cervical squamous cell carcinoma and promotes invasiveness through the non-catalytic C terminus
por: Carter, S A, et al.
Publicado: (2012)

Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum
por: Belinsky, S A, et al.
Publicado: (2007)

CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status
por: Gudmundsdottir, K, et al.
Publicado: (2003)

A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibilty and prognosis in malignant melanoma
por: Halsall, J A, et al.
Publicado: (2004)

Mutation analysis of the MSMB gene in familial prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2010)

Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer
por: Pal, T, et al.
Publicado: (2012)

Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer
por: Watters, A D, et al.
Publicado: (2002)

A DEAD-box RNA helicase mediates meiotic silencing by unpaired DNA
por: Sy, Victor T, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_plg803f3ut717gt27o7aepuov0